At Simmunome, collaboration is at the heart of our mission to revolutionize therapeutic development through advanced simulation technologies. We proudly partner with leading organizations, academic institutions, and industry innovators who share our vision of accelerating discoveries in biological research and transforming patient outcomes.
Partner with Simmunome.
Partners Form
NEURO-CERVO Alliance for Drug Discovery
The Neuro-CERVO Alliance has partnered with Montreal-based AI company Simmunome to understand neurological disease mechanisms and accelerate drug development.
CRCHUM, Université de Montréal's affiliated hospital research centre
Simmunome has partnered with CRCHUM, Université de Montréal's affiliated hospital research centre to develop therapeutics in neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease.
Mila - Québec Artificial Intelligence Institute
Simmunome has partnered with Mila - Québec AI Institute, the world’s largest academic deep learning research center.
